Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
False Claims Act penalizes inaccurate or misleading claims
Fatigue can appear early because retatrutide cuts intake while increasing fuel use
Blood tests may be conducted to measure your Vitamin B12 levels
Kirkland, Identification of a novel senolytic agent, navitoclax, targeting the Bcl2 family of antiapoptotic factors
Ovarian cancer is the sixth most common malignancy among women in developed countries and the fifth leading cause of cancer-related death, representing a complex disease associated with poor survival rates.24 The combination chemotherapy of Paclitaxel (PTX) and Carboplatin (CARB) is considered the first-line treatment regimen for ovarian cancer.25 Both agents play distinct roles in inhibiting the growth of ovarian cancer through different mechanisms,26 and they are known to exert a synergistic anti-tumor effect by activating separate apoptotic signaling pathways, thereby potentially reducing drug resistance.25 The gonadotoxic effects of platinum-based chemotherapeutic agents have been demonstrated in numerous studies, both histopathologically and in terms of follicular development.27-29 In the present study, CARB administration led to significant histopathological damage in ovarian tissue, including follicular degeneration, prominent stromal edema, congestion, hemorrhage, inflammation, and fibrosis, particularly in the medullary region
GSTZ1 deficiency leads to UDP-GlcUA accumulation, stabilizing TGFR1 mRNA by enhancing the interaction between TGFR1 and PTBP3, which in turn activates TGF/Smad signaling and promotes HCC migration [137]
US$ 24.94
US$ 26.63
US$ 26.67
US$ 22.97
US$ 23.66
US$ 28.24
